Davide Campari-Milano N.V (CPR) Fair Value & Analysis
Consumer Defensive · IT · Market cap €6.5B
Fair value as of: Jul 15, 2026
From 24 valuation models · updated 26 days ago
Share price +6.5% over the past month.
A solid business, but screening 16% overvalued on our models.
What matters now
- The model range is unusually wide (€2.82 to €7.58). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 15, 2026.
How to read this chart
60‑month range €5.01 – €12.88 · fair‑value band €2.82 – €7.58 · the €5.95 price screens above the €5.01 fair value. Dashed = 300-day average. As of Jul 15, 2026.
Analysis
Davide Campari-Milano N.V (CPR) currently trades at €5.95, while our model-based Fair Value estimate is €5.01, implying the stock looks roughly 15.8% overvalued today. The Quality Score stands at 54/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Davide Campari-Milano N.V generated revenue of €3.1B at a net margin of 11.4%. Revenue declined 2.8% year over year. It earns a return on equity of 8.6%. Net debt stands at €1.8B. Fundamentals as of Jul 15, 2026
Our scenario range runs from €2.82 (bear case) to €7.58 (bull case); at €5.95, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 12% below its 52-week high and 14% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at 6% fair-value upside, at -16%, CPR screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Growth Earnings (€5.32) versus Earnings-Based (€1.81). Highest evidence: Growth DCF (80).
Notify me when CPR reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 15, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 54 · Market factors (momentum, volatility) 47
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Davide Campari-Milano N.V., together with its subsidiaries, trades in alcoholic and non-alcoholic beverages in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific.
Full company description
Davide Campari-Milano N.V., together with its subsidiaries, trades in alcoholic and non-alcoholic beverages in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It offers a range of products, including aperitifs, vodka, whisky, rum, agave, cognac, and champagne under the Aperol, Campari, Picon, Cynar, Sarti Rosa, Campari Soda, Crodino, Aperol Spritz RTE, Wild Turkey, Appleton Estate, Wray and Nephew, The GlenGrant, Wilderness Trail, Espolòn, Ancho Reyes, Montelobos, Grand Marnier, Courvoisier, Bisquit, Champagne Lallier, SKYY Vodka, Bulldog Gin, Averna, Braulio, Forty Creek, Frangelico, Cabo Wabo, Del Professore, Mondoro, Riccadonna, La Mauny, Trois Rivieres, Kingston 62, O'ndina, Bickens, Dreher, Ouzo 12, Sagabita, and Zedda Piras brand names. Davide Campari-Milano N.V. was founded in 1860 and is headquartered in Sesto San Giovanni, Italy. Davide Campari-Milano N.V. operates as a subsidiary of Lagfin S.C.A.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Davide Campari-Milano N.V reported revenue of €3.1B in FY2025 versus €2.2B in FY2021, a compound +8.9%/yr. Reported net income was €346M in FY2025, compounding +5.0%/yr from FY2021.
of which total revenue +7.0 pp · buybacks/dilution +0.1 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
CPR screens 16% overvalued. Compare with Kweichow Moutai Co →
Peer Group
Beverages - Wineries & Distilleries · 96 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Beverages - Wineries & Distilleries median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 40/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Beverages - Wineries & Distilleries stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Kweichow Moutai Co 600519 | ¥1,251 | ¥1,238 | -1% |
| Diageo plc DEON | 1,487 MXN | 1,239 MXN | -17% |
| Wuliangye Yibin Co 000858 | ¥73.69 | ¥48.44 | -34% |
| Shanxi Xinghuacun Fen Wine Factory Co 600809 | ¥110.50 | ¥185.80 | +68% |
| Pernod Ricard SA RI | €65.24 | €76.68 | +18% |
| Luzhou Laojiao Co 000568 | ¥83.12 | ¥149.17 | +79% |
| Brown-Forman Corporation BFA | $26.60 | $28.15 | +6% |
| United Spirits Limited UNITDSPR | ₹1,376 | ₹440.56 | -68% |
| Thai Beverage Public Company Y92 | 0.4450 SGD | 0.6900 SGD | +55% |
| Jiangsu Yanghe Distillery Co 002304 | ¥38.08 | ¥27.82 | -27% |
Compare Davide Campari-Milano N.V with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Davide Campari-Milano N.V (CPR) overvalued or undervalued?
What is the fair value of CPR?
What is the quality score of CPR?
What is the revenue of Davide Campari-Milano N.V (CPR)?
What is the net profit margin of CPR?
Does Davide Campari-Milano N.V pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Davide Campari-Milano N.V and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.